/SRBCF
SRBCF Stock - Sirona Biochem Corp.
Healthcare|BiotechnologyOTC
$0.01+0.00%
+$0.00 (+0.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SRBCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.00
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.12
52W High$0.05
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $34,779 | $671,923 | $268,022 | $105,711 | $135,743 |
| Gross Profit | $-28,767 | $621,755 | $199,250 | $51,572 | $135,743 |
| Gross Margin | -82.7% | 92.5% | 74.3% | 48.8% | 100.0% |
| Operating Income | $-2,405,872 | $-3,568,322 | $-2,347,339 | $-4,039,520 | $-4,443,550 |
| Net Income | $-2,543,190 | $-3,557,804 | $-2,306,335 | $-4,133,724 | $-4,549,575 |
| Net Margin | -7312.4% | -529.5% | -860.5% | -3910.4% | -3351.6% |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.02 |
Company Overview
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SRBCFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2024
EPS Surprise History
Q1 23
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 22, 2025 | — | — | — | — |
Q4 2025 | Oct 16, 2025 | — | — | — | — |
Q2 2025 | Jun 18, 2025 | — | — | — | — |
Q2 2025 | Apr 29, 2025 | — | — | — | — |
Q1 2025 | Mar 28, 2025 | — | — | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 20, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 26, 2024 | — | $-0.00 | — | — |
Q3 2023 | Sep 29, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.00 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 28, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 28, 2022 | — | $-0.01 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.00 | — | — |
Q3 2021 | Sep 29, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 29, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SRBCF
What is SRBCF's current stock price?
Sirona Biochem Corp. (SRBCF) is currently trading at $0.01 per share. The stock has moved +0.00% today.
What is the analyst price target for SRBCF?
No analyst price targets are currently available for this stock.
What sector is Sirona Biochem Corp. in?
Sirona Biochem Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is SRBCF's market cap?
Sirona Biochem Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does SRBCF pay dividends?
No, Sirona Biochem Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANPCY
CelLBxHealth plc
$0.07
Mkt Cap: $0.0B
HMTXF
Hemostemix Inc.
$0.06
Mkt Cap: $0.0B
HOOK
HOOKIPA Pharma Inc.
$0.88
Mkt Cap: $0.0B
IMUC
EOM Pharmaceuticals Holdings, Inc.
$0.15
Mkt Cap: $0.0B
LVCLF
Algorae Pharmaceuticals Limited
$0.00
Mkt Cap: $0.0B
NUMIF
Numinus Wellness Inc.
$0.04
Mkt Cap: $0.0B
NYMXF
Nymox Pharmaceutical Corporation
$0.07
Mkt Cap: $0.0B
PPCB
Propanc Biopharma, Inc.
$0.71
Mkt Cap: $0.0B
QPTFF
Quest PharmaTech Inc.
$0.01
Mkt Cap: $0.0B
SYGGF
Synairgen plc
$0.00
Mkt Cap: $0.0B
Explore stocks similar to SRBCF for comparison